Role of GLP-1 receptor agonist in T2DM with Atherosclerotic Cardiovascular Disease- Dr PC Manoria at CSI Con 2021
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are used to treat type 2 Diabetes Mellitus. GLP-1 RAs drugs are very effective in lowering blood sugar levels. These Drugs are also beneficial in improving heart health and kidney function.
In this Video, Dr. Prof. P.C. Manoria explains the Role of Glucagon-like peptide-1 receptor agonists in T2DM with Atherosclerotic Cardiovascular Disease. The leading cause of death in People with Type 2 Diabetes Mellitus (T2DM ) is CVD. T2DM doubles the risk of CVD compared with adults without T2DM.